CGEM20270319P27
CGEM Mar 19 2027 27.00 Put (CGEM270319P00027000)
option OPRA

cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan's assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.